ArticleFoods (Basel, Switzerland)2026
Quantitative Phosphoproteomics Identifies Myofibrillar Protein Phosphorylation Mediated by Pyruvate Kinase M2 in Beef.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Pyruvate kinase M2 (PKM2) influences meat quality through glycolysis and also exhibits its moonlighting function as a protein kinase that catalyzes protein phosphorylation. However, it remains unclear whether PKM2 phosphorylates myofibrillar proteins, thereby affecting postmortem myofibrillar protein stability. This study investigates PKM2's non-canonical kinase function using quantitative phosphoproteomics and an in vitro myofibrillar protein incubation model to identify its phosphorylation substrates and functional impacts. The quantitative phosphoproteomics identified 441 phosphoproteins, 881 phosphopeptides, and 1040 phosphorylation sites. Notably, the myosin regulatory light chain (MRLC) was identified as a likely candidate phosphorylation substrate of PKM2 in vitro. The interaction between PKM2 and MRLC was confirmed using co-immunoprecipitation (Co-IP) and Western blotting. Furthermore, MRLC phosphorylation by PKM2 significantly inhibited its degradation and enhanced its stability. This work establishes an in vitro biochemical framework for the moonlighting role of glycolytic enzymes, suggesting a potential mechanistic pathway that might influence myofibrillar protein stability during meat aging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.